Avid Bioservices (CDMO) announced that leading independent proxy advisory firms Institutional Shareholder Services and Glass Lewis & Co. recommend that Avid stockholders vote “FOR” the Company’s pending transaction with GHO Capital Partners and Ampersand Capital Partners. Nick Green, president and CEO of Avid Bioservices, said, “We are pleased that ISS and Glass Lewis recognize the premium value of the GHO and Ampersand transaction for Avid stockholders, as well as the process run by our Board of Directors to ensure we are maximizing value. We encourage our stockholders to vote FOR our transaction with GHO and Ampersand today.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDMO:
- Avid Bioservices announces expiration of HSR waiting period for acquisition
- Avid Bioservices Reports Revenue Growth Amid Acquisition Plans
- Avid Bioservices reports Q2 EPS (27c), consensus (10c)
- Avid Bioservices downgraded to Equal Weight from Overweight at Stephens
- Avid Bioservices (CDMO) Can Exploit Potential U.S. BIOSECURE Act